Literature DB >> 20100011

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects.

Christina Fahrmayr1, Martin F Fromm, Jörg König.   

Abstract

Uptake transporters in the basolateral membrane of hepatocytes are important for the hepatobiliary elimination of drugs. Further, since drug-metabolizing enzymes are located intracellularly, uptake into hepatocytes is a prerequisite for their subsequent metabolism. Therefore, alteration of uptake transporter function (e.g., by concomitantly administered drugs or due to functional consequences of genetic variations, leading to reduced transport function) may result in a change in drug pharmacokinetics. In this review, we focus on the hepatocellularly expressed members of the OATP and OCT family, their impact on transport-mediated drug-drug interactions, and on the functional consequences of variations in genes encoding these transporters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100011     DOI: 10.3109/03602530903491683

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  23 in total

1.  Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.

Authors:  Eleni Aklillu; Sabina Mugusi; Eliford Ngaimisi; Michael Marcus Hoffmann; Sonja König; Victoria Ziesenitz; Gerd Mikus; Walter Emil Haefeli; Johanna Weiss
Journal:  Eur J Clin Pharmacol       Date:  2011-06-01       Impact factor: 2.953

Review 2.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats.

Authors:  Yifan Tu; Lu Wang; Yi Rong; Vincent Tam; Taijun Yin; Song Gao; Rashim Singh; Ming Hu
Journal:  Elife       Date:  2021-07-01       Impact factor: 8.140

Review 4.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

5.  Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2.

Authors:  Obinna N Obianom; Ana L Coutinho; Wei Yang; Hong Yang; Fengtian Xue; Yan Shu
Journal:  Mol Pharm       Date:  2017-07-21       Impact factor: 4.939

6.  Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells.

Authors:  C Fahrmayr; J König; D Auge; M Mieth; M F Fromm
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 7.  Interaction of innovative small molecule drugs used for cancer therapy with drug transporters.

Authors:  K Mandery; H Glaeser; M F Fromm
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 8.  Drug transporters, the blood-testis barrier, and spermatogenesis.

Authors:  Linlin Su; Dolores D Mruk; C Yan Cheng
Journal:  J Endocrinol       Date:  2010-12-06       Impact factor: 4.286

9.  Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors.

Authors:  Varun Khurana; Mukul Minocha; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Metabol Drug Interact       Date:  2014

Review 10.  Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.

Authors:  Rui Li; Hugh A Barton; Manthena V Varma
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.